======= MMP13 =======
== Gene Information ==
* **Official Symbol**: MMP13
* **Official Name**: matrix metallopeptidase 13
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4322|4322]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P45452|P45452]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MMP13&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MMP13|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/600108|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This protease cleaves type II collagen more efficiently than types I and III. It may be involved in articular cartilage turnover and cartilage pathophysiology associated with osteoarthritis. Mutations in this gene are associated with metaphyseal anadysplasia. This gene is part of a cluster of MMP genes on chromosome 11. [provided by RefSeq, Jan 2016].
* **UniProt Summary**: Plays a role in the degradation of extracellular matrix proteins including fibrillar collagen, fibronectin, TNC and ACAN. Cleaves triple helical collagens, including type I, type II and type III collagen, but has the highest activity with soluble type II collagen. Can also degrade collagen type IV, type XIV and type X. May also function by activating or degrading key regulatory proteins, such as TGFB1 and CTGF. Plays a role in wound healing, tissue remodeling, cartilage degradation, bone development, bone mineralization and ossification. Required for normal embryonic bone development and ossification. Plays a role in the healing of bone fractures via endochondral ossification. Plays a role in wound healing, probably by a mechanism that involves proteolytic activation of TGFB1 and degradation of CTGF. Plays a role in keratinocyte migration during wound healing. May play a role in cell migration and in tumor cell invasion. {ECO:0000269|PubMed:16167086, ECO:0000269|PubMed:17623656, ECO:0000269|PubMed:19422229, ECO:0000269|PubMed:19615667, ECO:0000269|PubMed:20726512, ECO:0000269|PubMed:22689580, ECO:0000269|PubMed:23810497, ECO:0000269|PubMed:8207000, ECO:0000269|PubMed:8576151, ECO:0000269|PubMed:8603731, ECO:0000269|PubMed:8663255, ECO:0000269|PubMed:9065415}.
|PG binding 1|
|Hemopexin|
|Peptidase M10|
|replacement ossification|
|endochondral ossification|
|growth plate cartilage development|
|endochondral bone growth|
|collagen catabolic process|
|bone growth|
|cartilage development involved in endochondral bone morphogenesis|
|bone mineralization|
|response to amyloid-beta|
|collagen binding|
|collagen metabolic process|
|extracellular matrix disassembly|
|endochondral bone morphogenesis|
|biomineralization|
|biomineral tissue development|
|organ growth|
|metalloendopeptidase activity|
|bone morphogenesis|
|cartilage development|
|bone development|
|connective tissue development|
|extracellular matrix|
|skeletal system morphogenesis|
|ossification|
|extracellular matrix organization|
|extracellular structure organization|
|developmental growth|
|growth|
|cellular component disassembly|
|response to peptide|
|skeletal system development|
|calcium ion binding|
|zinc ion binding|
|animal organ morphogenesis|
|response to organonitrogen compound|
|response to nitrogen compound|
|proteolysis|
|response to oxygen-containing compound|
|extracellular space|
|tissue development|
|extracellular region|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp280|Daidzin 10μM R06 exp280]]|-1.93|
|[[:results:exp318|ABT-702 5μM R07 exp318]]|-1.91|
|[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.88|
|[[:results:exp431|Rotenone 0.07μM R08 exp431]]|-1.76|
|[[:results:exp298|Sucrose 20000μM R06 exp298]]|1.73|
|[[:results:exp69|Deguelin 0.05μM R02 exp69]]|1.74|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6322
* **Expression level (log2 read counts)**: -2.96
{{:chemogenomics:nalm6 dist.png?nolink |}}